Antibody formulations and uses thereof

US10195281B2 · kind B2 · utility

Assignee

• Tracon Pharmaceuticals, Inc. · US

Inventors

• Suzanne Benedict · San Diego, US
• Mark Manning · Johnstown, US
• Brian Murphy · Fort Collins, US
• Sharon Real · Pennington, US
• Charles Theuer · San Diego, US

Key dates

• Filing date: Sep 5, 2013
• Grant date: Feb 5, 2019
• Expiry date: Dec 25, 2034

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/565
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present application relates to formulations of anti-CD105 antibodies, antigen-binding fragments thereof, and uses thereof. Another aspect relates to pre-filled syringes of the formulations of anti-CD105 antibodies or antigen-binding fragments thereof. Another aspect relates to the use of the formulations to reduce one or more signs or symptoms of an angiogenesis-related disorder such as cancers and ophthalmologic diseases.